home / stock / enfn / enfn articles
NEW YORK, March 23, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Enfusion, Inc. ("Enfusion" or the ...
A significant insider buy by Oleg Movchan, Chief Executive Officer at Enfusion (NYSE:ENFN), was executed on March 6, and reported in the recent SEC...
Goldman Sachs analyst Gabriela Borges downgraded Enfusion Inc (NYSE:ENFN) from Neutral to Sell and lowered the price target fro...
News, Short Squeeze, Breakout and More Instantly...
2024-07-01 05:24:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-11 07:28:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Enfusion, Inc. ("Enfusion") (NYSE: ENFN), a leading provider of software-as-a-service (SaaS) solutions for investment managers, today announced that Enfusion’s Chief Executive Officer, Oleg Movchan, and Chief Financial Officer, Brad Herring, and Chief Operating Officer, Neal Pawar, will pa...